Article

Impact of HER2-low Breast Cancer on Survival in Denmark: A Nationwide Investigation (2007-2019)

2023-07-06

Abstract excerpt

<h4>Background: </h4> With the development of new antibody-drug conjugates targeting the human epidermal growth factor receptor 2 (HER2), breast cancer (BC) with low levels of HER2 expression (HER2-low) is emerging as a potential distinct entity. Studies of HER2-low populations have found varying impacts on survival compared with HER2 0 BC. We, therefore, investigated the prognosis of breast cancer (BC) with low l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 90131fef-f5b3-5953-a82d-189ca4fbb00f
DOI: 10.21203/rs.3.rs-3125595/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Impact of HER2-low Breast Cancer on Survival in Denmark: A Nationwide Investigation (2007-2019)DOI 10.21203/rs.3.rs-3125595/v1Read

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studySemantic proximity Read

Clinical Significance and Genetic Characteristics in HER2 Low Expression Tumors of Hormone Receptor Positive Breast Cancer PatientsSemantic proximity Read

Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancerSemantic proximity Read

Discordance of HER2-low between primary tumors and matched distant metastases in breast cancerSemantic proximity Read

Low and Ultra-low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic SubtypesSemantic proximity Read

Molecular and clinical traits of HER2-low breast cancer patients and their relationship with neoadjuvant treatment effectiveness.Semantic proximity Read

Unveiling the mysteries of HER2-low expression in breast cancer: pathological response, prognosis, and expression level alterationsSemantic proximity Read

The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 statusSemantic proximity Read

Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes.Semantic proximity Read

Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other BiomarkersSemantic proximity Read

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast CancerSemantic proximity Read

Clinicopathological Characterization of HER2-Low-Expressing Triple-Negative Breast Cancer: Distinct Features From HER2-Zero Subtype.Semantic proximity Read